Symbol not found
:MYOV
Earnings Announcements
Myovant Sciences Announces Corporate Updates And Financial Results For Third Fiscal Quarter 2022
Published: 01/26/2023 22:31 GMT
Myovant Sciences Ltd (MYOV) - Myovant Sciences Announces Corporate Updates and Financial Results for Third Fiscal Quarter 2022.
Qtrly Total Revenues $100.2 Million Versus $54.4 Million.
Qtrly Net Loss per Common Share Basic and Diluted $0.59.
Q3 Earnings per Share View $-0.48, Revenue View $102.4 Million -- Refinitiv Ibes Data (analyst estimates).
Qtrly Total Revenues $100.2 Million Versus $54.4 Million.
Qtrly Net Loss per Common Share Basic and Diluted $0.59.
Q3 Earnings per Share View $-0.48, Revenue View $102.4 Million -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $244.82 Million
Adjusted EPS is expected to be $0.56
Next Quarter Revenue Guidance is expected to be $107 Million
Next Quarter EPS Guidance is expected to be -$0.57
More details on our Analysts Page.
Adjusted EPS is expected to be $0.56
Next Quarter Revenue Guidance is expected to be $107 Million
Next Quarter EPS Guidance is expected to be -$0.57
More details on our Analysts Page.